Paper42018554
Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target.
Luk JTF and 10 others. Prostate, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target. Papers, record 42018554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42018554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta-Analysis of a Potential Therapeutic Target.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Erb-b2 Receptor Tyrosine Kinases | Major topic |
| Humans | |
| Male | |
| Biomarkers, Tumor |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12173324 | HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial. | Cancer | 2002 | https://conductscience.org/library/papers/12173324 | PubMed |
| 2 | 34016991 | HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now. | NPJ Breast Cancer | 2021 | https://conductscience.org/library/papers/34016991 | PubMed |
| 3 | 12365012 | Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology. | Cancer | 2002 | https://conductscience.org/library/papers/12365012 | PubMed |
| 4 | 20812221 | Significant prognostic factor of immunohistochemical HER-2 expression using initial prostate biopsy specimens with M1b prostate cancer. | Prostate | 2011 | https://conductscience.org/library/papers/20812221 | PubMed |
| 5 | 22340411 | Prognostic value of Her-2/neu and clinicopathologic factors for evaluating progression and disease-specific death in Chinese men with prostate cancer. | Chin Med J (Engl) | 2011 | https://conductscience.org/library/papers/22340411 | PubMed |
| 6 | 39282896 | Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer. | N Engl J Med | 2024 | https://conductscience.org/library/papers/39282896 | PubMed |
| 7 | 41124210 | Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer. | N Engl J Med | 2025 | https://conductscience.org/library/papers/41124210 | PubMed |
| 8 | 38622987 | The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma. | Ann Diagn Pathol | 2023 | https://conductscience.org/library/papers/38622987 | PubMed |
| 9 | 38427749 | Comparison of molecular analysis results determined by next-generation sequencing to immunohistochemical indicators and clinicopathological parameters in prostate adenocarcinomas. | Indian J Pathol Microbiol | 2024 | https://conductscience.org/library/papers/38427749 | PubMed |
| 10 | 20690807 | Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US. | Cancer Invest | 2010 | https://conductscience.org/library/papers/20690807 | PubMed |
| 11 | 37628975 | Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628975 | PubMed |
| 12 | 11488070 | HER2 protein expression and gene amplification in androgen-independent prostate cancer. | Am J Clin Pathol | 2001 | https://conductscience.org/library/papers/11488070 | PubMed |
| 13 | 20530441 | Detection of HER2 amplification using the SISH technique in breast, colon, prostate, lung and ovarian carcinoma. | Anticancer Res | 2010 | https://conductscience.org/library/papers/20530441 | PubMed |
| 14 | 37867174 | Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis. | NPJ Breast Cancer | 2023 | https://conductscience.org/library/papers/37867174 | PubMed |
| 15 | 25124637 | Overexpression of HER-2/neu in patients with prostatic adenocarcinoma. | Asian Pac J Cancer Prev | 2014 | https://conductscience.org/library/papers/25124637 | PubMed |
| 16 | 24508693 | HER2 in breast cancer: a review and update. | Adv Anat Pathol | 2014 | https://conductscience.org/library/papers/24508693 | PubMed |
| 17 | 32939066 | Array programming with NumPy. | Nature | 2020 | https://conductscience.org/library/papers/32939066 | PubMed |
| 18 | 34277004 | The influence of testosterone suppression on HER2 immunoexpression in prostatic neoplastic tissue. | Mol Clin Oncol | 2021 | https://conductscience.org/library/papers/34277004 | PubMed |
| 19 | 11207822 | Overexpression of HER2/neu in solid tumours: an immunohistochemical survey. | Histopathology | 2001 | https://conductscience.org/library/papers/11207822 | PubMed |
| 20 | 32015543 | SciPy 1.0: fundamental algorithms for scientific computing in Python. | Nat Methods | 2020 | https://conductscience.org/library/papers/32015543 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42018554
GET https://conductscience.org/api/papers/v1/42018554/references?page=2